Related by context. All words. (Click for frequent words.) 72 interpersonal psychotherapy 70 psychoeducational 68 cognitive behavioral therapies 67 cognitive behavioral 66 neuropsychological assessment 65 TF CBT 65 psychodynamic psychotherapy 65 Cognitive behavioral 64 motivational interviewing 64 comorbid depression 64 Cognitive Behavioral Therapy 63 nonpharmacologic 62 psychodynamic therapy 62 behavioral interventions 62 psychotherapeutic 62 psychosocial 62 nonpsychotic 62 pharmacological interventions 62 somatic symptoms 61 comorbid disorders 61 Cognitive behavioral therapy 61 premorbid 61 pharmacologic treatments 61 somatoform disorders 61 semistructured 61 poststroke 61 guideline concordant 60 euthymic 60 psychotherapeutic interventions 60 MBCT 60 biopsychosocial 60 schizophrenia schizoaffective disorder 60 therapy CBT 60 ski lls 60 psychiatric comorbidities 60 meta analytic review 60 Motivational Interviewing 60 cognitive behavioral therapy 60 prodromal symptoms 60 interpersonal psychotherapy IPT 60 psychotherapies 60 somatization disorder 59 Cognitive Behavioral Therapy CBT 59 Psychodynamic 59 meta cognitive 59 Cognitive Behavioural Therapy 59 postdischarge 59 psychosocial interventions 59 Sociodemographic 59 pharmacotherapies 59 Cognitive Behavior Therapy 59 meta regression 59 affective disorders 59 sociodemographic characteristics 59 posttest 59 inhaled bronchodilators 59 CORE OM 58 Meta analyzes 58 neurocognitive functioning 58 comorbid diagnoses 58 depressive symptom 58 acupuncture biofeedback 58 postoperative AF 58 nonpharmacological 58 syndromal 58 subscales 58 alexithymia 58 Interpersonal psychotherapy 58 pharmacological approaches 58 dosing algorithm 58 hyperactivity inattention 58 cognitive affective 58 agomelatine 58 comorbid anxiety 58 dialectical behavioral 58 postintervention 58 pharmacological therapy 58 psychiatric comorbidity 58 empirically validated 58 Guided imagery 58 CONCERTA ® 58 MBSR 57 Pharmacologic 57 somatization 57 psychopharmacological 57 convergent validity 57 antioxidant supplementation 57 Secondary efficacy endpoints 57 BPS IC 57 allergen avoidance 57 psychiatric morbidity 57 symptom checklist 57 Relaxation techniques 57 biologic DMARDs 57 euthymic patients 57 sociodemographic variables 57 biopsychosocial model 57 Cognitive Behaviour Therapy 57 CPAP adherence 57 NMES 57 psychosocial rehabilitation 57 affective psychosis 57 hypochondriasis 57 dialectical behavior 57 relapse prevention 57 hyperarousal 57 nonpharmacological treatments 57 didactic lectures 57 subscale scores 57 pyridostigmine 57 antiepileptics 57 anticholinergic agents 57 antidepressant monotherapy 57 depressive symptomatology 57 psychosocial functioning 57 nutrient supplementation 57 prospective observational studies 57 psychodynamic 57 comorbid psychiatric disorders 57 methotrexate monotherapy 57 vestibular rehabilitation 57 noncardiac chest pain 56 inhaled budesonide 56 psychotherapeutic treatments 56 psychotherapy 56 constipation OIC 56 procedural sedation 56 CAM modalities 56 CIBIC plus 56 cognitive behavioral psychotherapy 56 DSM IV diagnoses 56 countertransference 56 cognitive stimulation 56 biofeedback therapy 56 CLBP 56 subthreshold depression 56 metaanalysis 56 schizophrenia bipolar disorders 56 suicide attempters 56 lipid lowering agents 56 poststroke depression 56 exploratory endpoints 56 comorbid psychiatric 56 psychiatric outpatients 56 Brief Psychiatric 56 Neuropsychiatric Inventory NPI 56 nondepressed 56 psychophysiological 56 EQ 5D 56 cognitive domains 56 psychosocial variables 56 vestibular disorders 56 symptom severity 56 symptomatology 56 Randomised controlled trial 56 nonepileptic seizures 56 PFPS 55 Cognitive Behavioural Therapy CBT 55 chronicity 55 neurocognitive function 55 tele ICU 55 inotropic agents 55 psychosocial distress 55 EEG biofeedback 55 GH deficiency 55 syndromic 55 desvenlafaxine succinate 55 mania hypomania 55 adenotonsillectomy 55 biobehavioral 55 dietary interventions 55 APTIVUS r 55 SSRI SNRI 55 metacognitive 55 osteopathic manipulation 55 pharmacotherapeutic 55 prospectively stratified 55 3D conformal radiation 55 Guided Imagery 55 depression suicidal ideation 55 Symptom severity 55 maladaptive behaviors 55 electrophysiologic 55 Neuropsychiatric Inventory 55 subscores 55 postdeployment 55 Montgomery Åsberg Depression 55 DPNP 55 HRQOL 55 Suicidal ideation 55 physiological nutritional 55 PCWP 55 neuroimaging studies 55 pharmacologic therapies 55 Posttraumatic Stress Disorder PTSD 55 neuroleptics 55 Helicobacter pylori eradication 55 fluoxetine paroxetine 55 pharmacological therapies 55 nonoperative 55 T1DM 55 adjunctive therapies 55 neuroleptic 55 Dialectical Behavior Therapy 55 Cognitive therapy 55 opioid dependent 55 semistructured interview 55 nighttime awakenings 55 lipid altering 55 meta analytic 55 HRQoL 55 #q# deletion syndrome 55 electro acupuncture 55 pain catastrophizing 55 preservice teachers 55 aldosterone antagonists 55 preintervention 55 antiarrhythmic drug 55 locomotor training 55 sociodemographic factors 54 varenicline Chantix 54 concomitant AEDs 54 Trained facilitators 54 non pharmacological interventions 54 adenoidectomy 54 STEP BD 54 Exclusion criteria 54 anorexia nervosa bulimia nervosa 54 HRQL 54 long acting bronchodilator 54 BPRS 54 multivariate analyzes 54 oral anticoagulation 54 neurocognitive impairment 54 dually diagnosed 54 neuropsychological evaluations 54 emotional dysregulation 54 dosage regimens 54 tolterodine 54 Attention-Deficit/Hyperactivity Disorder ADHD 54 nocturnal enuresis 54 posttreatment 54 subsyndromal 54 Structured Clinical 54 auditory visual 54 pathophysiological mechanisms 54 trastuzumab Herceptin ® 54 pharmacological treatments 54 Autistic Spectrum Disorders 54 diagnosing ADHD 54 p = .# [002] 54 antidepressive 54 telerehabilitation 54 Psychosocial interventions 54 noncognitive 54 hippocampal volumes 54 neuropsychological impairments 54 acupuncture meditation 54 analgesic medications 54 tapentadol IR 54 Schema Therapy 54 CI -#.# 54 Primary endpoints 54 living ADLs 54 nomograms 54 cluster randomized controlled 54 atypical neuroleptics 54 osteopathic manipulative treatment 54 CSHCN 54 depression schizophrenia bipolar 54 virological response 54 hypomanic episodes 54 dyslipidaemia 54 actigraphy 53 WBPA 53 cyclic HMB 53 neuromotor 53 mg Pycnogenol 53 psychosocial stressors 53 atherosclerotic renal artery stenosis 53 geriatric syndromes 53 occupational therapy physiotherapy 53 Y BOCS 53 ADLs 53 bipolar disorders 53 internalizing disorders 53 clevidipine 53 pramlintide metreleptin combination 53 acute subacute 53 shorter telomere length 53 cardiac autonomic 53 schizotypal 53 visceral metastases 53 ADHD symptoms 53 Reynolds Risk Score 53 covariate 53 dentin hypersensitivity 53 chiropractic manipulation 53 opiate dependence 53 erection hardness 53 psychometric properties 53 SYNTAX trial 53 ablative therapy 53 Poisson regression 53 biostatistical 53 sensory gating 53 NNT = 53 neuromuscular electrical stimulation 53 symptomatic hyponatremia 53 self directedness 53 HAM D# 53 Reprocessing EMDR 53 semistructured interviews 53 Postural 53 electrostimulation 53 Quantitative EEG 53 GI motility disorders 53 hypofractionated radiation 53 neurocognition 53 daytime alertness 53 behavioral modification 53 coadministration 53 psychomotor skills 53 dyadic 53 developmental trajectories 53 untreated psychosis 53 vasopressors 53 CYP#D# inhibitor 53 neurosensory 53 occupational therapists physiotherapists 53 Major Depressive Disorder 53 oral corticosteroids 53 tic severity 53 dose escalation phase 53 QoL 53 integrative therapies 53 ventilator weaning 53 amisulpride 53 polyarticular 53 Socio demographic 53 sociocultural context 53 diarrhea flatulence 53 succimer 53 corticosteroid dose 53 antithrombotic therapy 53 CAM therapies 53 nonpsychiatric 53 Mindfulness Based Cognitive Therapy 53 micronutrient supplementation 53 ragweed allergic 53 internalizing behaviors 53 genotypic resistance 53 pharmacodynamic endpoints 53 comorbid conditions 53 PANSS scores 53 prescribed antipsychotic medication 53 CIBIC + 53 HADS 53 neuropsychological functioning 53 lesional 53 divalproex sodium 53 Motivational interviewing 53 dysphoric 53 voiding dysfunction 53 Atypical antipsychotics 53 Ecotones Duet 52 dietary modification 52 oral prednisolone 52 OAB symptoms 52 androgen depletion 52 prospectively enrolled 52 ABVD 52 sociodemographic 52 venous thromboembolic disease 52 neuroanatomical 52 psychopharmacologic 52 interrater reliability 52 chronic prostatitis chronic 52 androgen excess 52 anxiety phobias 52 Secondary endpoints 52 HF ACTION 52 DSM IV criteria 52 rEEG ® 52 viral kinetics 52 pharmacodynamic parameters 52 hippocampal sclerosis 52 affective psychoses 52 inotropic 52 Freeze Framer 52 OneRecovery 52 antidepressant therapy 52 chronic periodontitis 52 randomized controlled trials RCTs 52 anticonvulsant medications 52 subscore 52 functional gastrointestinal disorders 52 phonophobia 52 methotrexate therapy 52 SRBD 52 intratympanic 52 generalized anxiety disorder GAD 52 Mood disorders 52 selective cyclooxygenase 2 52 comorbid ADHD 52 Decety 52 inattention hyperactivity 52 multisystemic 52 Attention-Deficit/Hyperactivity Disorder 52 somatoform 52 logistic regression models 52 WOMAC pain 52 Spinal manipulation 52 antiviral prophylaxis 52 Generalized Anxiety Disorder 52 schizophreniform disorder 52 dietary questionnaires 52 asthma exacerbations 52 topical NSAIDs 52 ICD implantation 52 Pulmonary rehabilitation 52 prazosin 52 DAS# scores 52 depersonalisation 52 buprenorphine naloxone 52 MBHO 52 Depressive Symptoms 52 physiologic responses 52 airway responsiveness 52 Alequel 52 Intensive Outpatient 52 logistic regression analyzes 52 Postnatal 52 probiotic supplementation 52 NSRT 52 neurophysiologic 52 overactive bladder symptoms 52 rEEG 52 Therapeutic hypothermia 52 RISPERDAL ® 52 chiropractic acupuncture 52 Comorbid 52 AGILECT R 52 Autism Spectrum Disorders ASDs 52 neurological impairments 52 therapists dieticians 52 Baseline characteristics 52 antiemetics 52 SGAs 52 inhaled corticosteroid therapy 52 antiangiogenic therapy 52 generalizability 52 Transcendental Meditation technique 52 LTRA 52 Distress Scale 52 Health Assessment Questionnaire 52 dopamine antagonists 52 OSAHS 52 Social Phobia 52 Tumor Response 52 CANCIDAS 52 relapsed MM 52 comorbid 52 BEXXAR Therapeutic Regimen 52 etiologic 52 Visual Analogue Scale VAS 52 aspirin clopidogrel 52 therapeutic regimens 52 triple nucleoside 52 thoracoscopic lobectomy 52 clinicopathological 52 generalisability 52 autonomic dysfunction 52 perinatal outcomes 52 premenopause 52 tiagabine 52 coronary CTA 52 EECP therapy 52 observational cohort 52 psychiatric inpatients 52 postoperative radiotherapy 52 ratio ICER 52 RCTs 52 NATRECOR R 52 psychosomatic medicine 52 Symptom Checklist 52 DMARD therapy 52 pharmacokinetic pharmacodynamic 52 QIDS SR 52 percutaneous vertebroplasty 52 neuropsychological deficits 52 daytime somnolence 52 differential gene expression 52 anticholinergic medication 52 parkinsonian 52 mindfulness exercises 52 noncardiovascular mortality 52 tonsillar hypertrophy 52 craniosacral therapy 52 somatic complaints 52 MMSE score 52 Subgroup analyzes 51 folinic acid 51 Medication adherence 51 trials RCTs 51 orally inhaled migraine 51 clinical pharmacology studies 51 CT urography 51 Comorbidity 51 urolithiasis 51 perfusion abnormalities 51 Posttraumatic 51 neurobehavioral 51 logistic regressions 51 acoustic startle 51 tryptophan depletion 51 psychoactive medications 51 GPRD 51 Personal CGM 51 psychostimulants 51 Ventricular Arrhythmias 51 overnight polysomnography 51 neuropsychiatric symptoms 51 df = 51 salmeterol fluticasone 51 EEG recordings 51 posttransplant 51 Actively participates 51 generalized epilepsy 51 hyperalgesia 51 anticonvulsant medication 51 androgen suppression 51 etiologic factors 51 bipolar disorder schizophrenia 51 bivariate analyzes 51 paroxetine Paxil 51 Mindfulness meditation 51 methodological approaches 51 Outcome Measures 51 meditation mindfulness 51 pharmacodynamic PD 51 clinically meaningful improvement 51 phonics fluency vocabulary 51 nonadherence 51 electroconvulsive therapy ECT 51 Randomized controlled 51 dissociative disorders 51 CIMZIA TM certolizumab pegol 51 electroencephalographic 51 presurgical 51 Buteyko breathing 51 serologic testing 51 audiometric 51 mild renal insufficiency 51 generalized anxiety disorder 51 citalopram Celexa 51 neurofeedback therapy 51 antenatal depression 51 neuroleptic drugs 51 tracheal intubation 51 psychosocial counseling 51 prosocial behavior 51 atypical antipsychotic medications 51 orofacial pain 51 High Functioning Autism 51 pharmacologic interventions 51 psychopathological symptoms 51 lipid lowering medication 51 haematologic 51 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 51 VADT 51 prospective longitudinal 51 C1 INH deficiency 51 hepatic metastases 51 interobserver 51 BoNTA 51 oral antidiabetes drugs 51 CMHCs 51 AGILECT ® 51 Retreatment 51 neuropsychological assessments 51 autism spectrum disorders ASD 51 empiric 51 HAQ DI 51 postexposure prophylaxis 51 pegylated interferon alfa 2b 51 ADEAR Center 51 attention-deficit/hyperactivity 51 interindividual variability 51 calcaneal fractures 51 inhaled glucocorticoids 51 concomitant medications 51 vasomotor 51 severe exacerbations 51 % CI #.#-#.# [003] 51 pharmacologic intervention 51 ICSs 51 PLMS 51 BMI z 51 risperidone Risperdal 51 malaria oral rehydration 51 external beam radiotherapy 51 hemodynamic measurements 51 chronic LBP 51 extrapleural pneumonectomy 51 preservice 51 paricalcitol 51 comorbid illnesses 51 tapentadol ER 51 PK PD modeling 51 olanzapine LAI 51 cortical excitability 51 intrapersonal 51 retrospective cohort 51 Relieve Depression 51 chromium picolinate supplementation 51 sleeve lobectomy 51 ambulatory settings 51 insulin detemir 51 androgen ablation 51 hypertension diabetes mellitus 51 Borderline Personality Disorder 51 preoperative chemotherapy 51 dyslipidemias 51 pharmacologic therapy 51 dysthymia 51 Acute Stress Disorder 51 dexmedetomidine 51 hydroxyurea therapy 51 See CLINICAL PHARMACOLOGY 51 reflux symptoms 51 coexisting illnesses 51 somatoform disorder 51 INVEGA ® 51 Systematic Treatment 51 EFFEXOR XR 51 radiochemotherapy 51 unstable angina UA 51 temozolomide TMZ 51 virologic responses 51 visual auditory 51 tic disorders 51 ritonavir boosted protease inhibitor 51 Chronic Heart Failure 51 Anti psychotics 51 mixed hyperlipidemia 51 polysomnographic 51 electroacupuncture 51 bivariate 51 laparoscopic bariatric surgery 51 Child Behavior Checklist 51 PREZISTA ritonavir 51 schizophrenia bipolar 51 aromatase inhibitors AIs 51 brainwave entrainment 51 EDSS scores 51 logistic regression 51 Cardiotoxicity 51 depressive symptoms 51 mGluR5 inhibitors 51 antiretroviral regimen 51 thyrotropin levels 51 autism Asperger Syndrome 51 nonoperative treatment 51 salivary cortisol 51 aspirin NSAIDs 51 Edinburgh Postnatal Depression 51 somatostatin analog 51 pentoxifylline 51 HIFU tumor 51 TEAEs 51 multiple logistic regression 51 polysomnogram 51 oral naltrexone 51 Polysomnography 51 odds ratios ORs 51 BENICAR HCT 51 neuropsychological tests 51 avoidant personality disorder 51 Nonspecific 51 PHQ 9 51 nonacute 51 multivariable Cox 51 DSM IV Axis 51 CT perfusion 51 nonsuicidal self injury 50 MMSE scores 50 interstitial brachytherapy 50 neurologic abnormalities 50 chemotherapy hormonal therapy 50 antidiabetic medications 50 serum estradiol 50 TM Sidhi 50 HoLEP 50 bulimia nervosa 50 Adjuvant chemotherapy 50 logistic regression model 50 Heritability 50 ADAS Cog 50 HbA 1C 50 temporomandibular disorders 50 intranasal corticosteroids 50 CRT ICD 50 adjuvant therapies 50 thromboprophylaxis 50 dual antiplatelet 50 CIMZIA ™ 50 carotid angioplasty 50 prospectively defined 50 pre operatively 50 generalized tonic clonic seizures 50 PNES 50 prodromal 50 attention-deficit/hyperactivity disorder 50 substance induced psychosis 50 ALISTA 50 QVAR R 50 reintubation 50 postoperative complication 50 venlafaxine Effexor 50 D Cycloserine 50 familial aggregation 50 histologically proven 50 cognitively intact 50 Valdoxan 50 longitudinal cohort 50 Atomoxetine 50 oral anticoagulant therapy 50 colorectal adenoma 50 mITT population 50 akinetic mutism 50 radicular pain 50 Coronary CTA 50 imipramine 50 clinicopathological features 50 psychotherapeutic treatment 50 antibiotic prophylaxis 50 relaxation techniques 50 coinfected patients 50 NIHSS 50 MDCT scans 50 EEG abnormalities 50 Asperger syndrome Rett syndrome 50 ADHD dyslexia 50 eNO 50 AChE inhibitors 50 osteopathic manipulative medicine 50 co trimoxazole prophylaxis 50 CranioSacral Therapy 50 certolizumab 50 Neuropsychological 50 conceptualizations 50 Thal Dex 50 oral corticosteroid 50 Relapse Prevention 50 clinico pathological 50 nonautistic 50 antidepressant efficacy 50 attention-deficit/hyperactivity disorder ADHD 50 prognostic variables 50 neuropsychological 50 BEXXAR therapeutic regimen 50 nondrug treatments 50 Obsessive compulsive disorder OCD 50 catheter ablations 50 symptom exacerbation 50 DAPT 50 LVRS 50 CPT coding 50 guanfacine extended release 50 pharmacologic 50 severe hepatic dysfunction 50 podiatric medical 50 convulsive disorders 50 % CI #.#-#.# [008] 50 clomipramine 50 postmenopausal osteoporotic women 50 left ventricular diastolic 50 morphometric vertebral fractures 50 placebo controlled clinical 50 Bipolar Depression 50 NHAMCS 50 bupropion SR 50 MDQ 50 interactional 50 manual lymphatic drainage 50 protease inhibitor PI 50 perfusion CT 50 Flu Cy 50 Breathing exercises 50 clinically meaningful reductions 50 Multiple logistic regression 50 parasomnias 50 IOP lowering 50 bolus dosing 50 substance misusers 50 IntroductionThe 50 randomisation 50 mindfulness meditation 50 acute mania 50 Fibromyalgia Impact Questionnaire 50 kinesthetic learners 50 dosimetric 50 spinal manipulative 50 diabetes mellitus DM 50 genotype phenotype 50 lenalidomide dexamethasone 50 levodopa carbidopa 50 sertraline 50 venlafaxine XR 50 abrupt discontinuation 50 opioid analgesia 50 psycho physiological 50 polytherapy 50 NAMI Connections 50 blinded randomized controlled 50 inotropes 50 covariates 50 antipsychotic induced 50 premenstrual symptoms 50 psychomotor 50 hippocampal neurogenesis 50 systemic corticosteroid 50 Clinical Antipsychotic Trials 50 integrative approaches 50 pediatric hospitalists 50 knee osteoarthritis OA 50 pathophysiologic mechanisms 50 stratifying patients 50 TomoMobile TM relocatable radiation 50 Psychotic Disorders 50 neuromusculoskeletal 50 inhaled bronchodilator 50 hypersomnia 50 tipranavir r 50 CriticalPoint 50 randomized discontinuation 50 PASI scores 50 MoxDuo TM IR 50 ischemia induced 50 β blockers 50 maximally tolerated lipid lowering 50 Zevalin consolidation 50 dose proportionality 50 antiretroviral naïve 50 HER2 overexpression 50 timepoints 50 MADRS score 50 episodic migraine 50 surgical debulking 50 recurrent glioblastoma multiforme 50 tacrolimus ointment 50 antidepressants SSRIs 50 neural substrates 50 Hill Rom enhancing 50 BMC Musculoskeletal Disorders 50 Interactive Metronome 50 HAMD 50 demonstrated clinically meaningful 50 TomoMobile ™ relocatable radiation 50 Mindfulness Based Stress Reduction 50 Clinical Somatics pain 50 kinesthetic learning 50 primary percutaneous coronary 50 neurocognitive 50 Suboptimal 50 therapy 50 parkinsonian symptoms 50 NMDA antagonists 50 Autism Spectrum Disorders ASD 50 undergoing coronary angiography 50 NYHA functional class 50 Comorbidities 50 causal inference 50 frontostriatal 50 BARI 2D 50 premenstrual dysphoric disorder 50 NIH CPSI 50 Neuropsychological Status 50 treating neuropathic pain 50 Generalised Anxiety Disorder 50 sensory impairments 50 cystoscopic 50 divalproex 50 Psychosocial 50 Autistic Spectrum Disorder 50 urodynamic parameters 50 GAMMAGARD 50 delusions hallucinations 50 iNO 50 paclitaxel eluting stents 50 hematologic parameters 50 developmental dyslexia 50 snoring sleep apnea 50 antihyperglycemic 50 SGRQ 50 receiving ISENTRESS 50 Fast ForWord Language 50 pharmacologic stress testing 50 verum acupuncture 50 mu opioid 50 acute postoperative 50 airway reactivity 50 psychobiological 50 Degenerative Disc Disease 50 inhaled tobramycin 50 plasma homocysteine 50 tai chi chih 50 Reiki acupuncture 50 schizophreniform 50 AutismPro 50 multiple sclerosis cerebral palsy 50 prenatal yoga classes 50 spinal manipulations 50 APTIVUS ritonavir 50 Skyland Trail 50 stepwise logistic regression 50 Schizoaffective Disorder 50 clinically meaningful improvements 50 acetazolamide 50 nosology 50 AAOS recommends 50 hypothalamic pituitary adrenal axis 50 DAS# CRP 50 intracortical 50 Depressive symptoms 50 IVIG therapy 50 HPA axis 50 posttraumatic 50 somatostatin analogs 50 comorbidity 50 acute respiratory tract infections 50 dysthymic disorder 50 NIHSS score 50 repetitive transcranial magnetic stimulation 50 opioid naïve 50 diarrhea predominant IBS 50 Venous thromboembolism 50 Insulin pump 50 suicide ideation 49 extramedullary 49 obsessions compulsions 49 tamoxifen Nolvadex ® 49 Mental Disorders DSM IV 49 Interpersonal Psychotherapy 49 patient centeredness 49 hemodynamic parameters 49 MGd 49 optometric vision 49 NICE guideline 49 affiliative 49 diabetic polyneuropathy 49 opioid naive 49 mechanistic studies 49 elicitation 49 non affective psychosis 49 neurocognitive dysfunction 49 cognitive 49 preoperative 49 aldosterone antagonist 49 pharmacologic approaches 49 multivariable analysis 49 neurobehavioral disorders 49 Dr. Taublieb provides 49 prognostic indicators 49 Score DAS 49 hemiplegic 49 GnRH agonists 49 therapeutic interventions 49 multivariate Cox 49 Charlson Comorbidity Index 49 endophenotypes 49 hyperlipidaemia 49 pathologic fractures 49 overt nephropathy 49 apnea hypopnea 49 oral hypoglycemic 49 Diagnostic Criteria 49 antiplatelet therapies 49 virological failure 49 nonrandomized 49 FinaMetrica 49 Natalizumab 49 Scale PANSS 49 androgen deprivation 49 sexual compulsivity 49 CT angiograms 49 concurrent chemoradiation 49 tolerability profiles 49 dissociative symptoms 49 oncologic outcomes 49 interventions 49 paroxetine sertraline 49 SF #v# 49 peri procedural 49 mean ± SEM 49 atherothrombotic 49 ejaculatory function 49 antiepileptic drugs AEDs